comparemela.com

Latest Breaking News On - தாலிஸ் உயிர் மருத்துவ - Page 1 : comparemela.com

Talis Biomedical (TLIS) Q2 2021 Earnings Call Transcript

Talis Biomedical (TLIS) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Talis: Q1 Earnings Snapshot

Talis: Q1 Earnings Snapshot Last Updated May 11, 2021 at 4:58 pm EDT MENLO PARK, Calif. (AP) Talis Biomedical Corp. (TLIS) on Tuesday reported a loss of $60.5 million in its first quarter. On a per-share basis, the Menlo Park, California-based company said it had a loss of $4.61. The infectious disease diagnostics company posted revenue of $7 million in the period. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TLIS at https://www.zacks.com/ap/TLIS The Associated Press Updated 18 minutes ago Clear! All lanes reopened. Latest Traffic audio element.

Earnings Scheduled For May 11, 2021

Companies Reporting After The Bell • VIZIO Holding (NYSE:VZIO) is estimated to report quarterly loss at $0.10 per share on revenue of $484.07 million. • Talis Biomedical (NASDAQ:TLIS) is likely to report quarterly loss at $10.80 per share on revenue of $230.00 thousand. • FAT Brands (NASDAQ:FAT) is estimated to report quarterly loss at $0.06 per share on revenue of $6.75 million. • Xenon Pharmaceuticals (NASDAQ:XENE) is likely to report quarterly loss at $0.40 per share on revenue of $5.15 million. • Sonim Technologies (NASDAQ:SONM) is expected to report quarterly loss at $0.10 per share on revenue of $12.97 million. • Invesco National AMT-Free Municipal Bond ETFo (NYSE:PZA) is likely to report earnings for its first quarter.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.